Amesite says NurseMagic now meets HIPAA requirements for all users
NurseMagic Compliance: Amesite announced that NurseMagic now complies with HIPAA requirements for all users, ensuring proper handling of sensitive healthcare information.
Business Growth: Following its previous compliance announcement for enterprises, Amesite reported an increase in B2B sales.
Trade with 70% Backtested Accuracy
Analyst Views on AMST
About AMST
About the author


- Acquisition Announcement: A consortium of private equity firms led by Permira and Warburg Pincus has announced a deal to acquire Clearwater Analytics for approximately $8.4 billion, including debt, indicating strong market interest in investment and accounting software companies.
- Stock Price Reaction: Clearwater Analytics shares surged 7.6% to $23.93 in pre-market trading, reflecting positive investor sentiment regarding the acquisition news, which may enhance the company's future market performance.
- Market Impact: This acquisition not only provides Clearwater Analytics with financial backing but also has the potential to accelerate its technological innovation and market expansion, strengthening its position in the highly competitive software industry.
- Industry Trend: With private equity firms continuing to invest in the software sector, more similar transactions are expected, further consolidating market resources and enhancing industry competitiveness.
- Product Expansion: Amesite's launch of the NurseMagic™ EMR marks a significant platform expansion, with customer onboarding expected to begin in January 2026, further solidifying its position in the post-acute care market.
- Revenue Growth: Following the May 2025 launch of Teams+, quarterly revenue surged 2.4x, and after the introduction of the Enterprise tier in Q4 2025, revenues increased by 82%, demonstrating the market appeal of higher-value offerings.
- Market Potential: The U.S. post-acute care market was valued at over $470 billion in 2024 and is projected to exceed $850 billion in the coming years, driven primarily by an aging population and rising chronic disease burdens.
- Customer Flexibility: The new EMR system allows for coexistence with existing systems or complete replacement, providing flexibility to meet customer needs, thereby enhancing Amesite's competitive sales advantage.

Revenue Growth: Amesite reported a 63% revenue growth from its NurseMagic enterprise product, with enterprise sales now exceeding B2C sales due to increased demand from post-acute care providers.
New AI Tool Launch: The company announced the launch of an AI-powered tool for automating government form-filling, addressing the rising scrutiny of documentation and the upcoming HOPE requirement for compliant submissions.

Launch of NurseMagic™ Enterprise Tier: Amesite Inc. has introduced the NurseMagic™ Enterprise Tier, designed for mid- and large-scale post-acute healthcare providers, featuring seamless EMR integration, automated reporting, and census-based pricing to enhance operational efficiency and support revenue growth.
Transition from Entry-Level Plans: The company will discontinue new sales of its entry-level B2B Teams plan, focusing instead on the NurseMagic™ Enterprise Tier and Teams Plus+, allowing for better value capture and stronger recurring revenue growth in the healthcare market.

Launch of NurseMagic Enterprise Tier: Amesite has introduced the NurseMagic Enterprise Tier to address the needs of mid- and large-scale post-acute healthcare providers, integrating AI-powered capabilities into existing workflows.
Market Growth Potential: By aligning pricing with patient census, Amesite aims to expand its addressable market and enhance long-term revenue growth.

NurseMagic™ Multilingual Support: Amesite Inc. has enhanced its NurseMagic™ app to support charting in 16 languages, addressing the needs of nearly 1 million ESL nurses in the U.S., which constitutes 19.2% of the nursing workforce.
Business Growth and Expansion: The company reported a 2.4x revenue increase due to the rapid adoption of NurseMagic™, while also launching a higher-priced enterprise tier to meet growing B2B demand, positioning itself for further domestic and international growth.




